Totally agree with you Dungiven...its time to get this moving...
Deals haven't been forthcoming...I think it's a combo of things as you state as well.
I know that once we get a green light for the final leg of the clinical program, it will up the prospects of a deal and thus non dilutive funding. I also agree with you, a dilutive CR is going to really hurt...I am fairly certain they will avoid that genuinely at all costs. A regional deal still has a chance of taking place...but I think it will be the milestones to come from a data and a clinical prospect that will start to lift the chances materially of us getting it all funded till the end of the trial, having a successful readout,NDA and then revenue finally beginning.
Totally agree with you Dungiven...its time to get this...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.030(10.9%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.5¢ | 24.0¢ | $429.9K | 1.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 161991 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 29634 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
-0.030 ( 7.51 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.0¢ | 23.5¢ | 433775 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| PAR (ASX) Chart |